List of Tables:
Table 1. Snapshot of Europe Pharmacovigilance and Drug Safety Software Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. Main Product Trends and Market Opportunities in Europe Pharmacovigilance and Drug Safety Software Market 35
Table 5. Europe Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 43
Table 6. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, $ mn 49
Table 7. Europe Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, $ mn 56
Table 8. Europe Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 63
Table 9. Europe Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, $ mn 67
Table 10. Europe Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 76
Table 11. Europe Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 84
Table 12. Germany Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 86
Table 13. Germany Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 86
Table 14. Germany Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 86
Table 15. U.K. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 89
Table 16. U.K. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 89
Table 17. U.K. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 89
Table 18. France Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 91
Table 19. France Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 91
Table 20. France Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 91
Table 21. Spain Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 93
Table 22. Spain Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 93
Table 23. Spain Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 93
Table 24. Italy Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 95
Table 25. Italy Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 95
Table 26. Italy Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 95
Table 27. Netherlands Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 97
Table 28. Netherlands Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 97
Table 29. Netherlands Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 97
Table 30. Pharmacovigilance and Drug Safety Software Market in Rest of Europe by Country, 2021-2031, $ mn 99
Table 31. Ab Cube: Company Snapshot 104
Table 32. Ab Cube: Business Segmentation 105
Table 33. Ab Cube: Product Portfolio 105
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. Europe Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of Europe Pharmacovigilance and Drug Safety Software Market 27
Figure 7. Percentage of Trial Participants by Country, 2015-2019 30
Figure 8. World Drug Discovery Market, 2019-2030, $ mn 31
Figure 9. Primary Restraints and Impact Factors of Europe Pharmacovigilance and Drug Safety Software Market 32
Figure 10. Investment Opportunity Analysis 36
Figure 11. Porters Fiver Forces Analysis of Europe Pharmacovigilance and Drug Safety Software Market 39
Figure 12. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, % of Revenue 44
Figure 13. Europe Addressable Market Cap in 2022-2031 by Functionality, Value ($ mn) and Share (%) 44
Figure 14. Europe Pharmacovigilance and Drug Safety Software Market by Functionality: Adverse Event Reporting Software, 2021-2031, $ mn 45
Figure 15. Europe Pharmacovigilance and Drug Safety Software Market by Functionality: Drug Safety Audits Software, 2021-2031, $ mn 46
Figure 16. Europe Pharmacovigilance and Drug Safety Software Market by Functionality: Issue Tracking Software, 2021-2031, $ mn 47
Figure 17. Europe Pharmacovigilance and Drug Safety Software Market by Functionality: Fully Integrated Software, 2021-2031, $ mn 48
Figure 18. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, % of Sales Revenue 50
Figure 19. Europe Addressable Market Cap in 2022-2031 by Clinical Phase, Value ($ mn) and Share (%) 50
Figure 20. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Pre-clinical, 2021-2031, $ mn 51
Figure 21. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase I, 2021-2031, $ mn 52
Figure 22. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase II, 2021-2031, $ mn 53
Figure 23. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase III, 2021-2031, $ mn 54
Figure 24. Europe Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase IV, 2021-2031, $ mn 55
Figure 25. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, % of Sales Revenue 57
Figure 26. Europe Addressable Market Cap in 2022-2031 by Method, Value ($ mn) and Share (%) 57
Figure 27. Europe Pharmacovigilance and Drug Safety Software Market by Method: Spontaneous Reporting, 2021-2031, $ mn 58
Figure 28. Europe Pharmacovigilance and Drug Safety Software Market by Method: Intensified ADR Reporting, 2021-2031, $ mn 59
Figure 29. Europe Pharmacovigilance and Drug Safety Software Market by Method: Targeted Spontaneous Reporting, 2021-2031, $ mn 60
Figure 30. Europe Pharmacovigilance and Drug Safety Software Market by Method: Cohort Event Monitoring, 2021-2031, $ mn 61
Figure 31. Europe Pharmacovigilance and Drug Safety Software Market by Method: EHR Mining, 2021-2031, $ mn 62
Figure 32. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, % of Revenue 64
Figure 33. Europe Addressable Market Cap in 2022-2031 by Delivery Mode, Value ($ mn) and Share (%) 64
Figure 34. Europe Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-premise Delivery, 2021-2031, $ mn 65
Figure 35. Europe Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-demand Delivery, 2021-2031, $ mn 66
Figure 36. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, % of Revenue 68
Figure 37. Europe Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 68
Figure 38. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Oncology, 2021-2031, $ mn 69
Figure 39. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Respiratory Disorders, 2021-2031, $ mn 70
Figure 40. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Cardiology, 2021-2031, $ mn 71
Figure 41. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Neurology, 2021-2031, $ mn 72
Figure 42. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Immunology, 2021-2031, $ mn 73
Figure 43. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Pain Management, 2021-2031, $ mn 74
Figure 44. Europe Pharmacovigilance and Drug Safety Software Market by Indication: Other Indications, 2021-2031, $ mn 75
Figure 45. Breakdown of Europe Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, % of Revenue 76
Figure 46. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 77
Figure 47. Europe Pharmacovigilance and Drug Safety Software Market by End User: Pharmaceutical and Biotechnology Companies, 2021-2031, $ mn 78
Figure 48. Europe Pharmacovigilance and Drug Safety Software Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 79
Figure 49. Europe Pharmacovigilance and Drug Safety Software Market by End User: Business Process Outsourcing Firms (BPOs), 2021-2031, $ mn 80
Figure 50. Europe Pharmacovigilance and Drug Safety Software Market by End User: Other End Users, 2021-2031, $ mn 81
Figure 51. Breakdown of European Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 83
Figure 52. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 84
Figure 53. Pharmacovigilance and Drug Safety Software Market in Germany, 2021-2031, $ mn 85
Figure 54. Pharmacovigilance and Drug Safety Software Market in U.K., 2021-2031, $ mn 88
Figure 55. Pharmacovigilance and Drug Safety Software Market in France, 2021-2031, $ mn 90
Figure 56. Pharmacovigilance and Drug Safety Software Market in Spain, 2021-2031, $ mn 92
Figure 57. Pharmacovigilance and Drug Safety Software Market in Italy, 2021-2031, $ mn 94
Figure 58. Pharmacovigilance and Drug Safety Software Market in Netherlands, 2021-2031, $ mn 96
Figure 59. Pharmacovigilance and Drug Safety Software Market in Rest of Europe, 2021-2031, $ mn 98
Figure 60. Growth Stage of Europe Pharmacovigilance and Drug Safety Software Industry over the Forecast Period 100
